Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$521,941
New position
Shares Held
16,040
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026VARCOV Co. holds $11,431,242 across 31 Biotechnology names. VKTX ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
18,504 | $1,045,290 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
14,875 | $1,043,481 | |
| 3 | RXRX |
Recursion Pharmaceuticals, Inc.
|
171,593 | $526,790 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
This page
|
16,040 | $521,941 | |
| 5 | CYTK |
Cytokinetics Inc
|
7,805 | $514,427 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
15,473 | $484,150 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
8,329 | $483,998 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
6,754 | $460,150 |
All Filings in VKTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $521,941 | 16,040 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||